Markova M, Hristov G. Reporting of R&D Costs Under IAS 38 – The Case of Biopharmaceutical Companies. НТ [Internet]. 2023 Jan. 13 [cited 2026 Jul. 22];(4):57-65. Available from: https://bjiep.e-dnrs.org/index.php/rp/article/view/5190